Splash Beverage invests CDN$300,000 in cannabinoid biopharmaceutical firm Avicanna
Splash Beverage Group completed a strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company, as part of its transformation into a cannabinoid healthcare platform. The investment signals Splash's strategic pivot toward regulated medical cannabinoid products with clinical evidence and healthcare integration.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day